Literature DB >> 23086377

Molecular neuropathogenesis of Alzheimer's disease: an interaction model stressing the central role of oxidative stress.

Roberto Rodrigues1, Mark A Smith, Xinglong Wang, George Perry, Hyoung-Gon Lee, Xiongwei Zhu, Robert B Petersen.   

Abstract

Alzheimer's disease (AD) exhibits a complex etiology that simultaneously manifests as a complex cellular, neurobiological, molecular, anatomic-physiological and clinical entity. Other significant psychiatric conditions, such as depression and schizophrenia, may also present with complex and concurrent clinical and/or molecular phenotypes. These neuropsychiatric pathologies also originate from both environmental and genetic factors. We analyzed the molecular phenotypes of AD and discuss them with respect to the classical theories, which we integrated into mechanisms that share molecular and/or anatomical connections. Based on these mechanisms, we propose an interaction model and discuss the model in light of studies that refute or support it. Given the spectrum of AD phenotypes, we limit the scope of our discussion to a few, which facilitates concrete analysis. In addition, the study of specific, individual pathogenic phenotypes may be critical to defining the complex mechanisms leading to AD, thereby improving strategies for developing novel therapies.

Entities:  

Year:  2012        PMID: 23086377      PMCID: PMC3475420          DOI: 10.2217/fnl.12.27

Source DB:  PubMed          Journal:  Future Neurol        ISSN: 1479-6708


  118 in total

1.  Cognitive and neural mechanisms of emotional memory.

Authors:  S Hamann
Journal:  Trends Cogn Sci       Date:  2001-09-01       Impact factor: 20.229

2.  Apolipoprotein E gender effects on cognitive performance in age-associated memory impairment.

Authors:  David Bartrés-Faz; Carme Junqué; Pedro Moral; Antoni López-Alomar; Josep Sánchez-Aldeguer; Imma C Clemente
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2002       Impact factor: 2.198

Review 3.  Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.

Authors:  A M Fagan; D M Holtzman
Journal:  Microsc Res Tech       Date:  2000-08-15       Impact factor: 2.769

4.  Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.

Authors:  David A Wolk; Bradford C Dickerson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

5.  A novel action of alzheimer's amyloid beta-protein (Abeta): oligomeric Abeta promotes lipid release.

Authors:  M Michikawa; J S Gong; Q W Fan; N Sawamura; K Yanagisawa
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

6.  Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium.

Authors:  C Konradi; J C Leveque; S E Hyman
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

7.  A single intermolecular contact mediates intramolecular stabilization of both RNA and protein.

Authors:  Valerie Calabro; Matthew D Daugherty; Alan D Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-27       Impact factor: 11.205

8.  Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study.

Authors:  Yonas E Geda; David S Knopman; David A Mrazek; Gregory A Jicha; Glenn E Smith; Selamawit Negash; Bradley F Boeve; Robert J Ivnik; Ronald C Petersen; V Shane Pankratz; Walter A Rocca
Journal:  Arch Neurol       Date:  2006-03

9.  Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

Authors:  Marwa Aboukhatwa; Laura Dosanjh; Yuan Luo
Journal:  Mol Neurodegener       Date:  2010-03-12       Impact factor: 14.195

10.  Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.

Authors:  P L Richey; S L Siedlak; M A Smith; G Perry
Journal:  Biochem Biophys Res Commun       Date:  1995-03-17       Impact factor: 3.575

View more
  5 in total

Review 1.  Hippocampal plasticity during the progression of Alzheimer's disease.

Authors:  E J Mufson; L Mahady; D Waters; S E Counts; S E Perez; S T DeKosky; S D Ginsberg; M D Ikonomovic; S W Scheff; L I Binder
Journal:  Neuroscience       Date:  2015-03-12       Impact factor: 3.590

2.  Up-regulation of β-amyloidogenesis in neuron-like human cells by both 24- and 27-hydroxycholesterol: protective effect of N-acetyl-cysteine.

Authors:  Paola Gamba; Michela Guglielmotto; Gabriella Testa; Debora Monteleone; Chiara Zerbinati; Simona Gargiulo; Fiorella Biasi; Luigi Iuliano; Giorgio Giaccone; Alessandro Mauro; Giuseppe Poli; Elena Tamagno; Gabriella Leonarduzzi
Journal:  Aging Cell       Date:  2014-02-25       Impact factor: 9.304

Review 3.  Early Alzheimer's and Parkinson's disease pathology in urban children: Friend versus Foe responses--it is time to face the evidence.

Authors:  Lilian Calderón-Garcidueñas; Maricela Franco-Lira; Antonieta Mora-Tiscareño; Humberto Medina-Cortina; Ricardo Torres-Jardón; Michael Kavanaugh
Journal:  Biomed Res Int       Date:  2013-02-07       Impact factor: 3.411

4.  Flavonol-rich dark cocoa significantly decreases plasma endothelin-1 and improves cognition in urban children.

Authors:  Lilian Calderón-Garcidueñas; Antonieta Mora-Tiscareño; Maricela Franco-Lira; Janet V Cross; Randall Engle; Mariana Aragón-Flores; Gilberto Gómez-Garza; Valerie Jewells; Humberto Medina-Cortina; Edelmira Solorio; Chih-Kai Chao; Hongtu Zhu; Partha S Mukherjee; Lara Ferreira-Azevedo; Ricardo Torres-Jardón; Amedeo D'Angiulli
Journal:  Front Pharmacol       Date:  2013-08-22       Impact factor: 5.810

5.  Traffic-Related Air Pollution, APOEε4 Status, and Neurodevelopmental Outcomes among School Children Enrolled in the BREATHE Project (Catalonia, Spain).

Authors:  Silvia Alemany; Natàlia Vilor-Tejedor; Raquel García-Esteban; Mariona Bustamante; Payam Dadvand; Mikel Esnaola; Marion Mortamais; Joan Forns; Barend L van Drooge; Mar Álvarez-Pedrerol; Joan O Grimalt; Ioar Rivas; Xavier Querol; Jesus Pujol; Jordi Sunyer
Journal:  Environ Health Perspect       Date:  2018-08-02       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.